February 2015

 

In this Issue

Perspectives on Consolidation

A candid look at the effects of hospital and industry consolidation on vascular health care.

Issue

Supplement

GUEST CHIEF MEDICAL EDITOR’S PAGE

Perspectives on Consolidation

By Michael R. Jaff, DO

COVER STORIES

Health System Winners in the Retail Revolution

Attributes of successful systems that prove it’s not just about size.

By Brian Contos

Ensuring Satisfaction and Quality Vascular Care as Hospitals Consolidate

Several years ago, Gary M. Ansel, MD, moved from a high-volume private practice into hospital employment, and more recently, when his hospital system began to expand, he took on the role of overseeing the entire system’s vascular division. In this interview, Dr. Ansel describes physician compensation models, job satisfaction, and efforts toward establishing high-quality care, regardless of which door a patient passes through.

Industry Consolidation: Impact on Start-Ups and Innovation

Robert A. Hopkins, Equity Research Director at Bank of America, discusses the current motivators for mergers and acquisitions and the future of funding for medical device development.

On Purchasing Power, Cost Control, and Device Decisions

In response to the growing pressure to cut costs within hospitals, the Cleveland Clinic tasked vascular surgeon Sean P. Lyden, MD, to act as Medical Director of Supply Chain. He spoke with Endovascular Today about his responsibilities in this role, the forces affecting device innovation and education, and the Clinic’s new group purchasing organization.

Expansion in a Time of Consolidation

With cost-cutting efforts underway at nearly every hospital, facility expansion and investment in new capital equipment might seem a tough sell to hospital administrators. But, that’s just what Barry T. Katzen, MD, and Miami Cardiac & Vascular have been working toward. Dr. Katzen discusses the institute’s decision to initiate a $120 million expansion, as well as the challenges of seeing the plan through in a daunting financial climate.

Industry Consolidation’s Potential Effects on Meetings and Physician Education

Endovascular Today asked for perspectives from leading conference organizers by posing the question, “To what degree are you concerned about how industry consolidation could affect support for vascular meetings and physician education?”

With Gary M. Ansel, MD; Barry T. Katzen, MD; Dierk Scheinert, MD; Roger M. Greenhalgh, MD; Sean P. Lyden, MD; and Frank J. Veith, MD

FEATURED TECHNOLOGY

Sponsored by Cardinal Health (formerly AccessClosure)

The MYNX ACE® Vascular Closure Device

Early experience demonstrates reliability and patient comfort.

By Rajesh M. Dave, MD, FACC, FSCAI

VESSEL UPDATE

Cerebral AVMs and Dural AVFs: Pathology and Management

The first of a three-part series on diagnosing, treating, and researching management options for intracranial malformations.

By Vivek A. Kumar, PhD; Ravi R. Vissapragada, MD; Lyahn K. Hwang, BS; Matthew R. Fusco, MD; Christopher S. Ogilvy, MD; And Ajith J. Thomas, MD

CHALLENGING CASE

Two Stick or Not Two Stick: Acute Thrombosis of Femoral-Femoral Bypass Graft Resulting in Critical Limb Ischemia

Revascularization in a patient with inflow disease of a left-to-right femoral-femoral bypass utilizing multiple access locations.

By John A. Phillips, MD

DEPARTMENTS

Innovations

A preview of today’s new products.

An Interview With Juan F. Granada, MD, FACC

The interventional cardiologist and Chief Innovation Officer for CRF shares his perspective on products new to the market and down the pipeline.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.